Happy New Year: Expert panel clears Oxford vaccine for India

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka

India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a consignment of 50,400 doses, while Bahrain to get 10,800 doses. Covishield developed by Serum Institute of India was loaded to cargo aircraft at Mumbai. The cargo aircraft left Mumbai airport as per schedule at 7:55 am for Manama. The vaccine consignment for Colombo, which delayed for 15 minutes, left at 9:00 am. Meanwhile, India has supplied vaccines to its neighbours under neighbourhood first policy. Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan, Bangladesh received vaccines. India sees international cooperation in the area of fight against Covid-19 as its duty. New Delhi has played the role of the first responder in the region.

SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 28. The consignment containing COVID-19 vaccine will be dispatched to Bahrain and Colombo today. India is helping other countries with the import of COVID vaccine amid the pandemic.

‘More India-made Covid vaccines will be introduced’: PM Modi at Davos Dialogue

Prime Minister Narendra Modi said India will soon make available many more covid-19 vaccines to other countries. He also highlighted India's success in the fight against Covid-19. PM Modi said that he wants to assured global business community that the situation will now change rapidly. “Many more India-made vaccines will soon be made available to the world. India's upcoming vaccines will help other countries to fight pandemic at swifter pace. I want to assure global business community that situation will now change rapidly,” he said. The prime minister was addressing the World Economic Forum's online Davos agenda summit.

PM visits Covid vaccine centre in Glasgow

Prime Minister Boris Johnson visits a Covid-19 vaccine centre in Glasgow. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

COVID pushes Portugal's hospitals to the brink

Portugal's epidemic has entered a "terrible" phase, Prime Minister Antonio Costa has admitted, and the surge in cases has left hospitals on the brink of collapse. Emily Wither reports.

PM visits Covid test laboratory in Glasgow

Prime Minister Boris Johnson visits the Lighthouse Laboratory at the Queen Elizabeth University Hospital campus in Glasgow, where coronavirus tests are processed. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

U.S. FDA authorizes second COVID-19 vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

U.S. FDA authorizes second vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

2nd COVID-19 vaccine set for OK in US with FDA panel endorsement

The FDA's Vaccines and Related Biological Products Advisory Committee has recommended the Emergency Use Authorization (EUA) to a COVID-19 vaccine made by Moderna.

Michael Gove: UK’s vaccine supply is assured

Michael Gove says that the UK’s supply of Covid-19 vaccines for the future has been assured amid threats from the European Union of vaccine export controls on AstraZeneca doses leaving the bloc. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Covid vaccine: Nepal thanks India as it begins immunisation, China trumped

Nepal launched Covid-19 immunisation after India sent vaccines. India sent 10 lakh doses of Covishield vaccines to Nepal as a gift. Nepal PM Oli thanked India and PM Modi for the vaccine consignment. The Serum Institute of India has tied up with AstraZeneca to manufacture Covishield. Thousands of Nepalese frontline workers are set to be vaccinated. Nepal PM said talks are on with India to get more vaccines at a proper price. Oli said, “We got an early chance to administer the Covid-19 vaccine. For this, I thank our neighbouring nation India, its government, the people, and especially Prime Minister Narendra Modi. They sent 10 lakh doses of vaccines to us as a grant within a week of the roll-out in India.” Meanwhile, China is yet to get clearance for its Sinopharm vaccine in Nepal. Nepal has had over 2.7 lakh total covid cases and over 2,000 deaths. Watch the full video for more.

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India. ‘Government should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said. The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved. The first phase of coronavirus vaccination is all set to begin on 16th January, 2021. Watch the full video for all the details.

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government. Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII). Around 30 crore people are being targeted for vaccination in phase 1. These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities. Watch the full video for more.

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains

ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine which is manufactured at Pune’s Serum Institute of India (SII). Covishield was the first vaccine in India to get the DCGI nod. Soon after, DCGI approved Covaxin. Watch the full video for more details.